Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Lamictal
Active Ingredient:	Lamotrigine 2mg
Dosage Form:	Chewable/dispersible tablet
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturer:	GlaxoSmithKline LLC, North Carolina, United States of America

*Product:*	Lamictal
Active Ingredient:	Lamotrigine 5mg
Dosage Form:	Chewable/dispersible tablet
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturers:	Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom GlaxoSmithKline Pharmaceuticals SA, Poznan, Poland

*Product:*	Lamictal
Active Ingredient:	Lamotrigine 25mg
Dosage Form:	Chewable/dispersible tablet
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturers:	Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom GlaxoSmithKline Australia Pty Limited, Melbourne, Australia GlaxoSmithKline Pharmaceuticals SA, Poznan, Poland

*Product:*	Lamictal
Active Ingredient:	Lamotrigine 50mg
Dosage Form:	Chewable/dispersible tablet
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturers:	GlaxoSmithKline Australia Pty Limited, Melbourne, Australia GlaxoSmithKline Pharmaceuticals SA, Poznan, Poland

*Product:*	Lamictal
Active Ingredient:	Lamotrigine 100mg
Dosage Form:	Chewable/dispersible tablet
New Zealand Sponsor:	GlaxoSmithKline NZ Limited
Manufacturers:	GlaxoSmithKline Australia Pty Limited, Melbourne, Australia GlaxoSmithKline Pharmaceuticals SA, Poznan, Poland

*Product:*	Medical Air
Active Ingredient:	Argon 1% Nitrogen 78% Oxygen 21%
Dosage Form:	Gas
New Zealand Sponsor:	Air Liquide New Zealand Limited
Manufacturer:	BOC Limited, Auckland, New Zealand

*Product:*	Panadol Osteo
Active Ingredient:	Paracetamol 665mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	GlaxoSmithKline Consumer Healthcare New Zealand ULC
Manufacturers:	GlaxoSmithKline Dungarvan Limited, Waterford, Ireland Glaxo Wellcome SA, Avenida de Extremadura 3, Burgos, Spain GlaxoSmithKline Australia Pty Limited, Sydney, Australia

*Product:*	RINVOQ
Active Ingredient:	Upadacitinib hemihydrate 15.4mg equivalent to upadacitinib 15mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	AbbVie Limited
Manufacturer:	AbbVie Ireland NL B.V., Sligo, Ireland

Dated this 25th day of July 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule